Colchicine for a Gout Flare: Why the Low Dose Works Better (and Stops the Diarrhea)

It is 3 a.m. Your big toe has its own heartbeat, and even the bed sheet feels like a knife. You stumble to the bathroom, shake out the colchicine your doctor gave you, and do what half the internet tells you to do: keep taking pills until the pain stops or you cannot leave the bathroom. The pain does ease. So does everything else. By morning you are camped out on the toilet, wondering whether the cure is worse than the flare.

This story shows up in every gout forum, every week, and most of it is avoidable. The diarrhea is not a sign that colchicine is “working.” It is a sign you took too much. The strange part is that researchers proved this fifteen years ago in a randomized trial, and the dose that causes the least stomach trouble works just as well as the dose that empties you out. Let me walk you through the numbers.

The Old Rule Was “Take It Until You Get Diarrhea”

For decades, colchicine was dosed in a weird way no other drug is. The old instructions were to take a pill every hour or two during a flare, keep going until the pain broke, and stop only when you got diarrhea or vomiting, whichever came first. Doctors treated the stomach side effects as the “endpoint.” In plain English: you were told to push the drug until your body forced you to quit.

That advice came from an era when colchicine had never been properly studied in modern trials. The U.S. Food and Drug Administration (FDA) did not approve colchicine for acute gout until 2009. The approval came with a study that quietly killed the old dosing rule, and the approved label now says the exact opposite of “until diarrhea.”

What the Randomized Trial Actually Found

In 2010, a team led by rheumatologist Robert Terkeltaub published the first multicenter, double-blind, placebo-controlled trial comparing colchicine doses head to head. The study enrolled people who started treatment within 12 hours of a flare beginning and split them into three groups.

One group got the old high-dose regimen: 1.2 mg up front, then 0.6 mg every hour for six hours, totaling 4.8 mg. A second group got a low-dose regimen: 1.2 mg, then one more 0.6 mg tablet an hour later, totaling 1.8 mg, and then nothing. The third group got placebo. The main question was simple: whose pain dropped by at least half within 24 hours without needing rescue medicine?

The pain results surprised people raised on the old dosing. About 37.8% of the low-dose group responded, versus 32.7% of the high-dose group and 15.5% of the placebo group. The lower dose worked as well as the higher one. Statistically, the two active regimens were equivalent; both beat placebo, and the extra three milligrams bought nothing.

A man holding his red and swollen big toe during a sudden nighttime gout flare
A person clutching the stomach beside a toilet, the classic diarrhea side effect of too much colchicine

Then came the stomach numbers, and this is where the gap is enormous. In the high-dose group, 40 of 52 people, 76.9%, got diarrhea. Nearly one in five, 19.2%, had severe diarrhea, and 17.3% vomited. In the low-dose group, 23.0% got diarrhea, and nobody had severe diarrhea or vomiting. The placebo group had diarrhea in 14% of people, which tells you a gout flare and a stressed stomach often travel together even without the drug.

Read that again. Cutting the dose by more than half gave up no meaningful pain relief and dropped the diarrhea rate from roughly 3 in 4 people to about 1 in 4, close to placebo. The odds of diarrhea on high-dose versus low-dose colchicine were striking: an odds ratio of 21.3 for high dose, 1.9 for low dose. The authors concluded that the low-dose regimen’s safety profile was indistinguishable from placebo.

An independent Cochrane review reached the same corner. Pooling the available randomized data, reviewers found high-dose colchicine caused roughly one extra case of diarrhea, vomiting, or nausea for every 2 people treated, a number needed to harm of 2. Low-dose colchicine showed no significant increase in side effects over placebo, while still beating placebo for pain relief, with a number needed to treat of about 5.

The Dose You Should Actually Take

The current FDA-approved dosing for a gout flare in adults with normal kidney and liver function is 1.2 mg at the first sign of a flare, followed by 0.6 mg one hour later. That is it. Three 0.6 mg tablets total, or six of the smaller 0.3 mg tablets, all within the first hour and change. The label specifically tells you not to repeat the treatment course for at least three days.

The 2020 American College of Rheumatology (ACR) guideline goes a step further and conditionally recommends low-dose colchicine over the old high-dose approach. The 2016 European League Against Rheumatism (EULAR) recommendations likewise support colchicine as a first-line flare option but stress the low-dose schedule, because the side effects are dose-dependent while the benefit largely is not.

Two practical points matter here. First, colchicine is a race you win by starting early, not by taking more. The trial only enrolled people within 12 hours of flare onset. Start it at the first twinge, when the toe feels a little warm and you know from experience what is coming. Wait two days and the same three tablets may do very little, which is exactly when desperate people start redosing and get into trouble. Second, the three-day waiting period exists for a reason. Colchicine hangs around in the body, and stacking courses is how people end up in the hospital.

Why Diarrhea Happens, and Why It Is a Warning Sign

Colchicine works by jamming a protein called tubulin, which cells need to build their internal scaffolding and divide. Your immune cells, the ones driving the fireworks in your toe, cannot migrate and pump out inflammatory signals as easily when tubulin is blocked. That is the benefit.

The problem is that the lining of your gut is made of the fastest-dividing cells in your body. When blood levels of colchicine run too high, those cells take the hit first, before anything else. The result is cramping, nausea, and watery diarrhea. Regulators in several countries put it bluntly in their drug labels: diarrhea and vomiting may be the first signs of toxicity, and the medicine should be stopped or reduced when they appear. In the Spanish and British labels, the wording is essentially stop immediately. Diarrhea on colchicine is not cleansing, not a flare being flushed out, and not something to push through. It is your gut absorbing more drug than it can handle.

The Combination That Can Actually Kill You

Here is the part that does not get enough attention, because it has nothing to do with diarrhea from a single flare. Colchicine is broken down by a liver enzyme called CYP3A4 and pumped out of cells by a transporter called P-glycoprotein. Some common drugs block both. If one of them enters your bloodstream while colchicine is in it, colchicine levels can spike to many times normal without your taking a single extra tablet.

The best-documented culprit is the antibiotic clarithromycin (brand name Biaxin), often prescribed for bronchitis and pneumonia. A Hong Kong study of 116 hospitalized patients given both drugs found that 9 of 88 people, 10.2%, who took them at the same time died. Baseline kidney impairment raised the risk of death roughly ninefold, and people who developed pancytopenia, a dangerous collapse of all blood cell lines, had a relative risk of death around 23-fold. The authors’ conclusion was direct: the two drugs should not be prescribed together.

Erythromycin, the antifungals ketoconazole and itraconazole, and the transplant medicine cyclosporine carry the same kind of warning. Grapefruit juice in large amounts nudges the same enzyme. Kidney disease and age make everything worse, because colchicine clears mostly through the kidneys. If you take colchicine regularly and a new antibiotic, antifungal, or transplant medicine shows up on your list, ask the prescriber about the interaction before you swallow it. We covered this specific combination in more detail in our piece on the fatal colchicine and clarithromycin interaction.

If Three Tablets Are Not Enough, Do Not Take More

What if you take the low dose and six hours later the toe is still screaming? Do not restart the bottle. You still have two real options, and both are guideline-supported first-line flare treatments in their own right: a nonsteroidal anti-inflammatory drug (NSAID) such as naproxen or indomethacin, if your kidneys, stomach, and heart can handle them, or a corticosteroid course or injection arranged through a clinician. A steroid injection straight into a swollen joint often works within a day or two, which we covered in the piece on steroid shots for gout flares.

If you cannot take NSAIDs, have kidney disease, or live in a country where colchicine tablets come in 0.5 mg rather than 0.6 mg, the dose has to be individualized. Do not convert it yourself in the dark at 3 a.m. A clinician who knows your kidney function can set the flare dose and the waiting period. People on dialysis should not use colchicine without specialist supervision, because the drug is not removed by dialysis and standard doses can build up to toxic levels.

One more scenario worth naming: people who take a small daily colchicine tablet to prevent flares, often during the first months of allopurinol or febuxostat. That is a completely different schedule, usually 0.6 mg once or twice a day, and it has its own rules. If a flare hits while you are already on daily colchicine, you do not simply stack the full flare dose on top. Why starting urate-lowering medicine provokes flares, and how the low daily dose prevents them, is explained in our article on starting febuxostat and the flare that follows.

Stomach Already Upset? What to Do Right Now

If you already overdid it and are dealing with diarrhea from a high-dose course, stop the colchicine. For ordinary mild diarrhea, the playbook is the boring one that works: sip water or an oral rehydration drink in small frequent amounts, eat bland food when you can face it, and expect things to settle within a day or two. Anti-diarrhea medicines such as loperamide are generally fine for short, uncomplicated diarrhea in healthy adults, but they do not fix the underlying drug buildup and should not be used to cover continued colchicine dosing.

Some situations need a clinician or an emergency department rather than the couch. Call for help if the diarrhea or vomiting will not stop, you cannot keep fluids down, you feel faint or confused, you notice blood or a black stool, or you have significant kidney disease and took a standard or high dose. Muscle weakness, tingling, unusual bruising, or a fever after colchicine can mean the rarer toxicities, nerve and muscle injury or bone marrow suppression, and they are not something to wait out at home.

Frequently Asked Questions

How much colchicine should I take for a gout flare?

For adults with normal kidney and liver function, the FDA-approved flare dose is 1.2 mg at the first sign of the flare, followed by 0.6 mg one hour later, for 1.8 mg total. Do not repeat the course for at least three days. In the randomized trial, this schedule produced pain relief similar to a 4.8 mg high-dose regimen, with diarrhea rates close to placebo instead of the roughly 77% seen with high dosing.

Is diarrhea a sign colchicine is working?

No. Diarrhea means your gut lining is seeing more drug than it can tolerate. The old “take it until diarrhea” rule came from before modern trials existed. The 2010 study showed the lower, diarrhea-sparing dose works just as well. Drug labels describe diarrhea and vomiting as possible first signs of toxicity and say to stop or reduce the dose when they occur.

Can I take colchicine with ibuprofen or naproxen?

There is no direct interaction between colchicine and nonsteroidal anti-inflammatory drugs, and clinicians sometimes combine them briefly, but both groups of drugs can be hard on the body in different ways, NSAIDs on kidneys and stomach, colchicine on the gut. Stacking medicines on your own during a flare is risky if you have kidney disease, take blood thinners, or have an ulcer history. That combination is a clinician’s call, not a 3 a.m. experiment.

What happens if I take colchicine with clarithromycin?

Clarithromycin blocks the pathways that clear colchicine and can push its blood levels into the toxic range, even without an overdose. In a study of hospitalized patients given both drugs, about 1 in 10 people taking them together died, with risk concentrated in people with kidney impairment. Do not take them together unless a prescriber has explicitly adjusted the colchicine dose, and mention the interaction any time you are prescribed an antibiotic.

Why does colchicine work when ibuprofen does not?

They attack a flare from different angles. NSAIDs quiet the inflammatory signal broadly, while colchicine specifically stops immune cells from reacting to the urate crystals. Neither works well late in a hard flare, and individual responses differ. If over-the-counter NSAIDs are not touching an attack, the answer is usually an early clinician visit for a stronger option, not more colchicine. Our piece on why ibuprofen sometimes fails walks through the reasons.

References

  1. Terkeltaub RA, Furst DE, Bennett K, Kook KA, Crockett RS, Davis MW. “High versus low dosing of oral colchicine for early acute gout flare: twenty-four-hour outcome of the first multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison colchicine study.” Arthritis and Rheumatism. 2010;62(4):1060-1068. PMID: 20131255. doi:10.1002/art.27327
  2. van Echteld I, Wechalekar MD, Schlesinger N, Buchbinder R, Aletaha D. “Colchicine for acute gout.” The Cochrane Database of Systematic Reviews. 2014;(8):CD006190. PMID: 25123076. doi:10.1002/14651858.CD006190.pub2
  3. FitzGerald JD, Dalbeth N, Mikuls T, Brignardello-Petersen R, Guyatt G, et al. “2020 American College of Rheumatology Guideline for the Management of Gout.” Arthritis Care & Research. 2020;72(6):744-760. PMID: 32391934. doi:10.1002/acr.24180
  4. Richette P, Doherty M, Pascual E, Barskova V, Becce F, et al. “2016 updated EULAR evidence-based recommendations for the management of gout.” Annals of the Rheumatic Diseases. 2017;76(1):29-42. PMID: 27457514. doi:10.1136/annrheumdis-2016-209707
  5. Slobodnick A, Shah B, Pillinger MH, Krasnokutsky S. “Colchicine: old and new.” The American Journal of Medicine. 2015;128(5):461-470. PMID: 25554368. doi:10.1016/j.amjmed.2014.12.010
  6. Hung IF, Wu AK, Cheng VC, Tang BS, To KW, et al. “Fatal interaction between clarithromycin and colchicine in patients with renal insufficiency: a retrospective study.” Clinical Infectious Diseases. 2005;41(3):291-300. PMID: 16007523. doi:10.1086/431592
  7. Hui M, Carr A, Cameron S, Davenport G, Doherty M, et al. “The British Society for Rheumatology Guideline for the Management of Gout.” Rheumatology (Oxford). 2017;56(7):e1-e20. PMID: 28549177. doi:10.1093/rheumatology/kex156
  8. U.S. National Library of Medicine, DailyMed. “Colchicine tablet: prescribing information (Colcrys).” National Institutes of Health. Accessed October 16, 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cc0e205a-697e-d47e-e053-2995a90a154e

Reviewed by the GoutSavvy Editorial Team